EUVIMEDEUVIMED entdecken
Crossref

Enantioselective Synthesis of a Key Intermediate toward Dragmacidin E via Base-Promoted Olefin Isomerization–Ir-Catalyzed Asymmetric Hydrogenation Sequence

Noa Takahashi, Shingo Harada, Tetsuhiro Nemoto

Chemical and Pharmaceutical Bulletin · 2025

DOI: 10.1248/cpb.c25-00703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2025. Verfasst von Noa Takahashi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan. Hauptthemen laut MEDLINE: Alkenes, Iridium. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkenesIridiumHydrogenationStereoisomerismCatalysisMolecular Structure

Stichwörter der Autor:innen

asymmetric synthesisdragmacidin Enatural producttotal synthesis

Substanzen

AlkenesIridium

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

Zitieren

APA

Takahashi, N., Harada, S., & Nemoto, T. (2025). Enantioselective Synthesis of a Key Intermediate toward Dragmacidin E via Base-Promoted Olefin Isomerization–Ir-Catalyzed Asymmetric Hydrogenation Sequence. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c25-00703

Vancouver

Takahashi N, Harada S, Nemoto T. Enantioselective Synthesis of a Key Intermediate toward Dragmacidin E via Base-Promoted Olefin Isomerization–Ir-Catalyzed Asymmetric Hydrogenation Sequence. Chemical and Pharmaceutical Bulletin. 2025. doi:10.1248/cpb.c25-00703

BibTeX
@article{Takahashi2025,
  author = {Takahashi, Noa and Harada, Shingo and Nemoto, Tetsuhiro},
  title = {Enantioselective Synthesis of a Key Intermediate toward Dragmacidin E via Base-Promoted Olefin Isomerization–Ir-Catalyzed Asymmetric Hydrogenation Sequence},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/cpb.c25-00703}
}
Kostenlos starten →